Trent’s bonus share issue is approaching its record date of June 4. The company will issue one bonus share for every two held. Analysts suggest investors should not buy Trent shares solely for the bonus. Focus should remain on the company’s growth and earnings potential. Trent’s stock has seen a decline over the past year but shows strong long-term gains.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,